Keyword: Arena Pharmaceuticals
News
17.02.2023
-
Safety findings in Phase 2 clinical trials have forced Aristea Therapeutics to stop developing its lead candidate RIST4721 for treating serious immune-mediated...
News
07.01.2013
- Vivus said prescriptions for obesity drug Qsymia, its main product, rose nearly 68% in the month ended Dec. 21 compared with the preceding four weeks, well above industry forecasts...
News
28.06.2012
- U.S. health regulators approved the first new weight-loss drug in 13 years, allowing Arena Pharmaceuticals to bring its Belviq pill to market as public health advocates push for...
